Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma
The prognosis of aggressive adult T-cell leukemia/lymphoma (ATL) is poor, and allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative treatment. In order to identify favorable prognostic patients after intensive chemotherapy, and who therefore might not require upfront allo-HSC...
| 出版年: | Haematologica |
|---|---|
| 主要な著者: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Ferrata Storti Foundation
2023-02-01
|
| オンライン・アクセス: | https://haematologica.org/article/view/10979 |
